Showing results (1-10 of 159) with videos related to
Sort By:
Pageof 16
Pharmacology & Therapeutics|December 3, 2011
The PSD-95/nNOS complex: new drugs for depression?Marika V Doucet, Andrew Harkin, Kumlesh K DevNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 2013
Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in miceMarika V Doucet, Hester Levine, Kumlesh K Dev, et al.Nature Reviews. Drug Discovery|December 2, 2004
Making protein interactions druggable: targeting PDZ domainsKumlesh K DevCurrent Topics in Medicinal Chemistry|February 3, 2007
PDZ domain protein-protein interactions: a case study with PICK1Kumlesh K DevJournal of Cell Science|September 12, 2015
Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signallingCatherine O'Sullivan, Kumlesh K DevBiomedicines|May 27, 2023
The Effects of Antipsychotics in Experimental Models of Krabbe DiseaseKapil Sharma, Kumlesh K DevDrug Discovery Today. Therapeutic Strategies|April 15, 2020
RNA interference as a therapeutic strategy for treating CNS disordersDaniel Hoyer, Kumlesh K DevDrug Discovery Today|August 27, 2013
Drug dealers: $20 trillion of in-licensing paymentsPatrik Frei, Kumlesh K DevTrends in Pharmacological Sciences|June 15, 2013
The structure and function of the S1P1 receptorCatherine O'Sullivan, Kumlesh K DevPageof 16